北京绿竹生物技术股份有限公司（股票代码：02480）于2026年7月3日披露6月股份变动月报，报告期为截至2026年6月30日。公告显示，公司本月期间并无新增发行、回购或注销股份，股本结构保持稳定。
根据公告，绿竹生物-B于报告期末普通股H股的法定/注册股本为人民币2.02亿元（202,449,032股，面值每股人民币1元），与上个月持平。其中，已发行股份数量198,913,232股，库存股份数目3,535,800股，合计202,449,032股，较上月同样无变化。公司确认已符合截至本月末的适用公众持股量要求。
此外，本月关于公司股份期权与股权激励计划、可换股票据、任何其他协议或安排以及购回和注销等均无新增或变动。公司同时确认所有证券发行及库存股份交易均已履行相关内部批准及外部监管程序，并按照香港联交所《上市规则》及相关法律法规进行。
本次月报由公司秘书刘斯宇签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.